Cardiovascular disease and cold homes

Cardiovascular disease and cold homes have one of the cleanest dose-response curves in housing-health epidemiology. Indoor temperature drops, blood pressure rises. Cold snaps arrive, myocardial infarction admissions rise. Excess winter deaths in the UK consistently track housing thermal performance more tightly than they track clinical care quality.

For the cardiovascular patient — the post-MI rehab case, the hypertensive who is not at target, the older patient with multimorbidity — the home is part of the prescription. This page sets out the evidence and a working pathway for clinicians and households.

Blood pressure elevation in cold environments

The physiological mechanism is straightforward: cold exposure triggers peripheral vasoconstriction to preserve core temperature, raising systemic vascular resistance and therefore blood pressure. The effect is rapid (minutes) and sustained for as long as the exposure continues. In a home that holds 16°C overnight and 18°C during the day, an older or vasomotor-sensitive patient is sitting on elevated blood pressure for the entire heating season.

Typical magnitudes seen in observational studies and home-temperature monitoring:

For a hypertensive patient who is being titrated towards target on antihypertensives, the cold-home effect can offset the entire pharmacological effort. This is rarely measured, because BP is taken in a clinic at 21°C, not at the patient's kitchen table at 14°C.

MI and stroke seasonality

UK and European data consistently show winter peaks in myocardial infarction and ischaemic stroke admissions. The seasonality is not pure temperature — viral infection, dehydration, and behavioural factors contribute — but the temperature signal is independently significant after adjustment.

What this means in pathway terms: a patient discharged after MI in October enters a six-month window of elevated risk. The home temperature during that window matters as much as the medication adherence.

Post-MI rehabilitation in unheated homes

Cardiac rehabilitation is one of the most cost-effective post-MI interventions. The evidence is strong, the protocols are well-developed, and the structured exercise component requires the patient to be able to move at moderate intensity in a comfortable environment. A cold home undermines the rehab in two ways:

• The patient cannot warm up properly, so any exertion happens against an already-vasoconstricted vascular bed
• The patient self-rations activity to avoid feeling cold, defeating the rehabilitation principle

Where a patient is identified as at risk during cardiac rehab assessment, the OT or rehab nurse can record home temperature concerns and trigger a referral. This is one of the highest-yield moments for housing intervention because the patient is already engaged with multidisciplinary care.

NICE guidance and the heating prescription

NICE guidance on excess winter deaths (NG6) recommends that healthcare professionals identify patients at risk from cold homes and refer them to local authority or community services. The mechanism is well-established but underused in practice. Most patients at risk are not formally identified, and most identified patients do not receive a follow-through.

The 'heating prescription' concept reframes this: heating, like medication, is something the clinician records, recommends, and follows up on. The prescription consists of:

• Identification — note in the record that the patient is at cardiovascular risk from cold exposure
• Recommendation — minimum bedroom and living room temperatures (18-21°C in heating season)
• Referral — to retrofit assessor and grant eligibility checker, with the medical letter as supporting documentation
• Follow-up — at the next review, ask about home temperature alongside medication adherence

Heart failure and the temperature-sensitive case

Heart failure is the cardiovascular condition where the housing relationship most closely tracks day-to-day clinical status. Fluid balance, exertion tolerance, and decompensation risk all interact with indoor environment in ways that can be measured at the bedside. A heart failure patient living in a 16°C home is performing more cardiovascular work simply to maintain core temperature than the same patient at 21°C — and that work shows up in fluid retention, breathlessness, and reduced exercise tolerance.

The community heart failure nurse is well-placed to identify the housing component because the visits are typically in the home environment. A simple thermometer reading at the visit, with a note in the record if the room is below 18°C in heating season, creates a documented signal that supports a retrofit referral. Many heart failure pathways now incorporate this, but practice is uneven.

When to add a heating-grant prescription

Concrete decision criteria for adding a heating-grant referral to the cardiovascular care plan:

• Patient is post-MI within 6 months and reports cold home or fuel poverty
• Patient is post-stroke and lives alone in older housing stock
• Hypertension not at target despite adequate pharmacological intervention, and patient describes cold home
• Heart failure (NYHA II or worse) — fluid balance and exertion tolerance are temperature-sensitive
• Older patient (75+) on cardiovascular medication living in property pre-1980 without recent insulation work
• Any patient on the Severe Mental Illness or Disability registers with cardiovascular comorbidity (qualifies for ECO4 flex)
• Atrial fibrillation patient on rate or rhythm control where cold-induced symptom worsening is reported
• Cardiac rehab participant whose progress plateaus during winter months

The referral routes are the same as for respiratory conditions: a PAS 2035 assessment that scopes whole-house retrofit, plus a grant eligibility check that maps to ECO4, GBIS, or Home Upgrade Grant. For cardiovascular patients specifically, the medical letter should reference NICE NG6 (excess winter deaths and morbidity) as the supporting framework — most local authority ECO4 flex officers recognise this reference.

Practical retrofit priorities for cardiovascular patients

Where the assessor confirms scope, the priority order for cardiovascular cases is slightly different from the general population. Heating responsiveness matters more than absolute thermal performance — a heart failure patient needs the home to recover quickly from a cold spell, not just to be theoretically efficient. Practical priorities:

1. Heating system that delivers consistent indoor temperature without long warm-up periods (heat pump with weather compensation, or modern condensing combi with smart controls)
2. Insulation focused on the rooms the patient actually uses (often bedroom and living room rather than whole house, especially in older patients)
3. Draught-proofing — disproportionately effective for thermal comfort and inexpensive
4. Bedroom temperature monitoring with simple smart thermostat for night-time minimum
5. Ventilation strategy that doesn't sacrifice temperature stability — MVHR is ideal where envelope supports it

For renters, the same priority list applies but the conversation shifts to landlord engagement. The Awaab's Law framework, while focused on damp and mould, has shifted the wider conversation about minimum habitation standards.

The cardiovascular care plan that ignores indoor temperature is incomplete. The home is the environment in which the prescription operates, and a cold home is a confounder large enough to overwhelm the pharmacology.